KCM
IMGN

Kynam Capital Management’s Immunogen Inc IMGN Stock Holding History

Kynam Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,422,503
Closed -$42.2M – 26
2023
Q4 		$42.2M Buy
+1,422,503
New +$28.3M 4.67% 7

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Kynam Capital Management's IMGN Position: Q1 2024 in Review

Kynam Capital Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,422,503 shares — an estimated $42.2M sold.

Kynam Capital Management first reported a position in IMGN in Q4 2023 and held it in 1 quarter. The position peaked at $42.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Kynam Capital Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Kynam Capital Management sold 1,422,503 Immunogen Inc shares in Q1 2024, an estimated $42.2M.
  • Kynam Capital Management first reported a position in Immunogen Inc in Q4 2023 and held it in 1 quarter.
  • Kynam Capital Management's Immunogen Inc position peaked at $42.2M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Kynam Capital Management's 13F filing for Q1 2024, filed 15 May 2024.